JPH0622746A - Frozen dry substance on microorganism containing medium and its preparation - Google Patents

Frozen dry substance on microorganism containing medium and its preparation

Info

Publication number
JPH0622746A
JPH0622746A JP4159776A JP15977692A JPH0622746A JP H0622746 A JPH0622746 A JP H0622746A JP 4159776 A JP4159776 A JP 4159776A JP 15977692 A JP15977692 A JP 15977692A JP H0622746 A JPH0622746 A JP H0622746A
Authority
JP
Japan
Prior art keywords
freeze
microorganism
containing medium
carbohydrate
dried product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4159776A
Other languages
Japanese (ja)
Other versions
JP2558203B2 (en
Inventor
Rawel Eckhard
ラウエル エックハルト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP4159776A priority Critical patent/JP2558203B2/en
Publication of JPH0622746A publication Critical patent/JPH0622746A/en
Application granted granted Critical
Publication of JP2558203B2 publication Critical patent/JP2558203B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

PURPOSE: To obtain a freeze-dried material of storage-stable under a relatively simple storage condition by making a microorganism-containing medium containing a bacterium keeping viability and fertility contain a carbohydrate, gelatin and ascorbic acid at a specific ratio and freeze-drying the resultant medium.
CONSTITUTION: This freeze-dried material is obtained by culturing a bacterium such as a strain of Acidophilus or a strain of Bifidobacterium in a culturing solution constituted with milk powder and a suitable nutritive agent so as the bacterium to be a stationary growing phase, and adding a carbohydrate (preferably milk sugar, etc.), gelatin, ascorbic acid in a dried weight ratio of (16/1/0.1)-(16/1/1) (preferably mixing them so as a dried weight ratio of the bacterium culturing solution, carbohydrate, gelatin and ascorbic acid to be 2/16/1/0.2) and mixed, and subjecting the resultant mixture to freeze-drying.
COPYRIGHT: (C)1994,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、凍結乾燥した状態で数
年間保存した後も生存能,生殖能を有する細菌で、特に
アシト゛フィルス(Acidophilus)の菌株、ヒ゛フィト゛ハ゛クテリウム(Bifidob
acterium) の菌株、エシェリヒア コリ(Escherichia coli) の菌
株における微生物含有培地の凍結乾燥物とその製造方法
に関するものである。
FIELD OF THE INVENTION The present invention relates to a bacterium which has viability and reproductive ability even after being stored in a freeze-dried state for several years, and in particular, a strain of Acidophilus, Bifidobterium.
The present invention relates to a freeze-dried product of a microorganism-containing medium in a strain of Escherichia coli (acterium) and a strain of Escherichia coli and a method for producing the same.

【0002】[0002]

【従来の技術】従来、種々の医薬品、血液製剤、酵素製
品、実験材料等で、長期に渡って保存が必要な場合の一
方法として、凍結乾燥法が使用されている。前記凍結乾
燥を行うにあたっては、湿度、温度、及び大気中の酸素
による生存能・生殖能の劣化をできるだけ抑えるため、
凍結乾燥前の微生物含有培地中に種々の補助剤、分散
剤、保護剤、担体等の添加剤が投与され、その凍結乾燥
物を低温は勿論、常温による保存に対しても安全性保存
が可能なように工夫されている。
2. Description of the Related Art Conventionally, a freeze-drying method has been used as a method for storing various medicines, blood products, enzyme products, experimental materials, etc. for a long period of time. In performing the freeze-drying, in order to suppress the deterioration of the viability and fertility due to humidity, temperature, and oxygen in the atmosphere as much as possible,
Various additives such as auxiliary agents, dispersants, protective agents and carriers are administered to the microorganism-containing medium before freeze-drying, and the freeze-dried product can be stored safely not only at low temperature but also at room temperature. It is devised like this.

【0003】一方、近年、食物の消化の補助的役割を果
たす大腸菌、バクテリオイデス、ユウバクテリウム、ビ
フィズス菌、乳酸桿菌等の腸内細菌を、ヨーグルト等の
乳酸製品に配合して健康維持食品を製造することが一般
化しつつあり、前記健康維持食品の製造に当たり、使用
する微生物(細菌)を好条件にて凍結乾燥できることが
考えられている。
On the other hand, in recent years, enteric bacteria such as Escherichia coli, Bacteroides, Eubacterium, Bifidobacteria, and Lactobacillus, which play an auxiliary role in the digestion of food, have been mixed with lactic acid products such as yogurt to provide health-maintaining foods. Manufacturing is becoming common, and it is considered that microorganisms (bacteria) to be used can be freeze-dried under favorable conditions in manufacturing the health-maintaining food.

【0004】[0004]

【発明が解決しようとする課題】ところが、高度に感受
性が相違する数種類の微生物(細菌)を同培地にて凍結
乾燥をするに際しては、そのための前記凍結乾燥前の微
生物含有培地中に投与する種々の補助剤、分散剤、保護
剤、担体等の添加剤の条件が問題となる。
However, in freeze-drying several kinds of microorganisms (bacteria) with highly different sensitivities in the same medium, various administrations are carried out in the microorganism-containing medium before freeze-drying for that purpose. The condition of additives such as auxiliary agent, dispersant, protective agent, carrier and the like is a problem.

【0005】本発明は、前記問題点を鑑みてなされたも
のであり、前記凍結乾燥物の製造時に使用する微生物含
有培地中に投与する添加剤の検討を行い、前記微生物
(細菌)を凍結乾燥し、その後、その凍結乾燥物が数年
間に渡り、比較的単純な貯蔵条件下(8°C以下の遮光
防湿状態)にて、生存能や生殖能を確実に保証するため
だけでなく、常温下(通常の大気中の室内条件下)に
て、該凍結乾燥物を市販可能製品に処理できるような微
生物含有培地の凍結乾燥物とその製造方法を提供するこ
とを課題としている。
The present invention has been made in view of the above problems, and an additive to be administered into a microorganism-containing medium used in the production of the freeze-dried product was examined to freeze-dry the microorganism (bacteria). However, after that, the freeze-dried product was kept for a few years under a relatively simple storage condition (shade-proof condition at 8 ° C or less) not only to ensure the viability and fertility, but also at room temperature. It is an object of the present invention to provide a freeze-dried product of a microorganism-containing medium and a method for producing the same, which allows the freeze-dried product to be processed into a commercially available product under the conditions (normal indoor conditions in the atmosphere).

【0006】[0006]

【課題を解決するための手段】本発明は、上記課題を解
決するために、次の技術的手段を講じる。
The present invention takes the following technical means in order to solve the above problems.

【0007】即ち、凍結乾燥の数年後も生存能・生殖能
を有することが可能な細菌、特にアシト゛フィルス(Acidophilu
s)の菌株、ヒ゛フィト゛ハ゛クテリウム(Bifidobacterium) の菌株、エ
シェリヒアコリ(Escherichia coli) の菌株における微生物含有
培地の凍結乾燥物に関し、前記微生物含有培地として、
炭水化物:ゼラチン:アスコルビン酸をその乾燥重量
比、16:1:0.1〜16:1:1にて混合したもの
を用い、この培地を凍結乾燥することで凍結乾燥物を製
造し、その凍結乾燥物が長期に渡って安定性保存できる
ようにしたことを特徴としている。
[0007] That is, bacteria capable of viability and reproduction even after several years of freeze-drying, especially Acidophilus (Acidophilu)
s) strain, Bifidobacterium (Bifidobacterium) strain, Escherichia coli (Escherichia coli) strains of the lyophilized product of the microorganism-containing medium, as the microorganism-containing medium,
Using a mixture of carbohydrate: gelatin: ascorbic acid in a dry weight ratio of 16: 1: 0.1 to 16: 1: 1, a freeze-dried product was produced by freeze-drying this medium, The feature is that the dried product can be stably stored for a long period of time.

【0008】前記高度に異なる感受性を有する細菌を懸
濁し、凍結乾燥して、通常の温度及び湿度下で処理する
ことが可能となると共に、8°C以下の冷房内の乾燥状
態で、少なくとも3年以上、高度の安定性(生存能や生
殖能の補償)を保持できるようにするため、前記凍結乾
燥物の凍結乾燥前の微生物含有培地中に種々の補助剤、
分散剤、保護剤、担体等の添加剤が投入される。
It is possible to suspend the bacteria having the above-mentioned highly different sensitivities, freeze-dry them, and process them under normal temperature and humidity, and at least 3 at a temperature of 8 ° C or less in a dry state. In order to maintain a high degree of stability (compensation of viability and fertility) for more than a year, various auxiliary agents in the microorganism-containing medium before freeze-drying the freeze-dried product,
Additives such as a dispersant, a protective agent and a carrier are added.

【0009】本発明では、その添加剤の検討を行い、主
に補助剤、或いは保護剤として作用する炭水化物,ゼラ
チン,アスコルビン酸を適宜乾燥重量比にて組み合わ
せ、下記に示す実施例1〜15の培地を使用して凍結乾
燥物を作製し、更にその凍結乾燥物の長期保存安定性を
凍結乾燥直後の単位当たりのコロニー形成数(CFU/
g)と数年後のコロニー形成数(CFU/g)との比較
により調べ、該凍結乾燥物中の細菌の生存率(%)にて
安定性保持力を判断した。
In the present invention, the additives are investigated, and carbohydrates, gelatin, and ascorbic acid, which mainly act as an auxiliary agent or a protective agent, are combined in an appropriate dry weight ratio, and the additives of Examples 1 to 15 shown below are used. A freeze-dried product was prepared using a medium, and the long-term storage stability of the freeze-dried product was determined by the number of colony formation per unit immediately after freeze-drying (CFU /
g) and the number of colonies formed after several years (CFU / g) were compared, and the stability of retention was judged by the survival rate (%) of the bacteria in the freeze-dried product.

【0010】[0010]

【作用】本発明の凍結乾燥物は微生物含有培地中の補助
剤、或いは保護剤として、炭水化物,ゼラチン,アスコ
ルビン酸を乾燥重量比で16:1:0.1〜16:1:
1にて投入しているので、それらの相互作用によって、
この凍結乾燥物は、低温下(4〜8°C)は勿論、常温
下においても、湿度、温度、及び大気中の酸素による生
存能や生殖能の劣化を充分に抑制し、長期的に安全性保
存が可能となる。
The freeze-dried product of the present invention comprises carbohydrates, gelatin and ascorbic acid in a dry weight ratio of 16: 1: 0.1 to 16: 1: as auxiliary agents or protective agents in a microorganism-containing medium.
Since it is input in 1, due to their interaction,
This lyophilized product is long-term safe by sufficiently suppressing deterioration of viability and fertility due to humidity, temperature and oxygen in the atmosphere not only at low temperatures (4 to 8 ° C) but also at room temperature. It is possible to preserve sex.

【0011】[0011]

【実施例】以下、本発明の凍結乾燥物及びその製造方法
の実施例について表及びグラフに基づき説明する。尚、
実施例1〜15で使用した培地の一覧表を表1に記す。
EXAMPLES Examples of the freeze-dried product of the present invention and a method for producing the same will be described below with reference to tables and graphs. still,
Table 1 shows a list of the culture media used in Examples 1 to 15.

【0012】[0012]

【表1】 [Table 1]

【0013】本実施例で使用した細菌はアシト゛フィルス(Acido
philus)の一種であるラクトハ゛チルス カ゛ッセリー (Lactobacillus
gasseri) の菌株、ヒ゛フィト゛ハ゛クテリウム(Bifidobacterium) の
一種であるヒ゛フィト゛ハ゛クテリウム ロンク゛ム (Bifidobacterium lon
gum)の菌株、エシェリヒア コリ(Escherichia coli) の菌株の3
種である。
The bacterium used in this example is Acidophilus
philus), a type of Lactobacillus
gasseri), a type of Bifidobacterium (Bifidobacterium), which is a type of Bifidobacterium lon
gum) and 3 strains of Escherichia coli
It is a seed.

【0014】《実施例1》先ず、各々の細菌を細菌培養
液(I) (全乳、或いは粉乳と適当な栄養剤から構成され
ている。)中で各々の細菌が定常成長相になるまで培養
する。
Example 1 First, each bacterium was placed in a bacterial culture solution (I) (composed of whole milk or milk powder and an appropriate nutrient) until each bacterium became a stationary growth phase. Incubate.

【0015】次に、前記細菌が含有された培養液250
0ml中に、乳糖、ゼラチン、アスコルビン酸の組み合わ
せによる添加剤(II)を混合して懸濁培地(微生物含有培
地)を作製する。
Next, a culture solution 250 containing the bacterium
A suspension medium (microorganism-containing medium) is prepared by mixing 0 ml of the additive (II), which is a combination of lactose, gelatin and ascorbic acid.

【0016】前記添加剤(II)の作製方法は、先ず、80
0g の乳糖(DAB 9) を1500mlの精製水(DAB 9) 中で
加熱しながら溶解し、その液中にブルーム200のゼラ
チン(DAB 9) 50g を加熱(37°Cで)しながら溶解
する。
The method for preparing the additive (II) is as follows.
0 g of lactose (DAB 9) is dissolved in 1500 ml of purified water (DAB 9) with heating, and 50 g of Bloom 200 gelatin (DAB 9) is dissolved with heating (at 37 ° C.).

【0017】一方、23g のアスコルビン酸(DAB 9) を
240mlの精製水(DAB 9) 中で溶解し、10%重量/容
積の水酸化ナトリウム5g を用いて中性化(pH6.0
以上)し、このアスコルビン酸の中和液を前記乳糖とゼ
ラチンの混合溶液に加え、3種混合液を作製し、この混
合液を添加剤(II)として使用する。
On the other hand, 23 g of ascorbic acid (DAB 9) was dissolved in 240 ml of purified water (DAB 9) and neutralized (pH 6.0) with 5 g of 10% weight / volume sodium hydroxide.
Then, the neutralized solution of ascorbic acid is added to the mixed solution of lactose and gelatin to prepare a mixed solution of three kinds, and this mixed solution is used as an additive (II).

【0018】次に、前記微生物含有培地を一定圧力下に
て凍結乾燥し、凍結乾燥物を作製する。
Then, the microorganism-containing medium is freeze-dried under a constant pressure to prepare a freeze-dried product.

【0019】更に、前記凍結乾燥によって得られた凍結
乾燥物を、例えばメッシュサイズ0.75mmの乾式粒子用篩
にて、通常の室内条件下で粉砕し、次いで、粉砕された
種々の凍結乾燥物をジャイロホイールミキサー内で混合
均質化し、例えば硬質ゼラチンのプラグ−オン型カプセ
ル中に充填してカプセル剤とする。
Further, the freeze-dried product obtained by the freeze-drying is crushed under normal indoor conditions with a sieve for dry particles having a mesh size of 0.75 mm, and then various crushed lyophilized products are crushed. Mix and homogenize in a gyro wheel mixer and fill into, for example, hard gelatin plug-on capsules to form capsules.

【0020】そして、該カプセル剤の形にて、前記凍結
乾燥物を低温(4°C〜8°C)、常温(20°C〜2
5°C)、高温(30°C及び40°C)にそれぞれ設
定された貯蔵室(勿論湿度一定、遮光状態)中で3年以
上保存し、その後、保存安定性試験を行うことにする。
ただし、継続試験を行う故、保存途中で貯蔵室より取り
出すカプセル剤がいくつも存在する。
Then, the freeze-dried product in the form of the capsule is treated at low temperature (4 ° C to 8 ° C) and normal temperature (20 ° C to 2 ° C).
5 ° C.) and high temperature (30 ° C. and 40 ° C.) are set for storage for 3 years or more in a storage room (of course, humidity is constant and light is shielded), and then a storage stability test is performed.
However, because of the continuous test, there are several capsules that are taken out of the storage room during storage.

【0021】前記保存安定性試験は、微生物学における
通常の方法を用い、特定期間それぞれの条件下に保存さ
れた凍結乾燥物を貯蔵室から取り出し、一定の実験培地
にて希釈して希釈系列をつくり、それぞれゲル状の実験
培地上で適当期間培養し、その後、単位当たりのコロニ
ー形成数(CFU/g)をカウントする。この数を対数
目盛りにてプロットすることで微生物(細菌)の指数関
数的生存率が換算され、この結果から細菌の生存能・生
殖能の劣化を知ることができ得る。
The above-mentioned storage stability test uses a usual method in microbiology, and the freeze-dried product stored under each condition for a specific period is taken out from the storage room and diluted with a fixed experimental medium to prepare a dilution series. After culturing, the cells are cultured on a gel-like experimental medium for an appropriate period of time, and thereafter, the number of colonies formed (CFU / g) per unit is counted. By plotting this number on a logarithmic scale, the exponential survival rate of the microorganism (bacteria) is converted, and from this result, the deterioration of the viability / fertility of the bacterium can be known.

【0022】尚、コントロールとして、凍結乾燥直後
(保存日数0日)に前記保存安定性試験を前記のように
行ったものを用いる。
As a control, the one subjected to the storage stability test as described above immediately after freeze-drying (0 days of storage) is used.

【0023】《実施例2》本実施例では、上記実施例1
の乳糖に代えて、ショ糖を用いた。その他の操作につい
ては実施例1と同様である。
<< Embodiment 2 >> In this embodiment, the above-mentioned embodiment 1 is used.
Sucrose was used instead of lactose. Other operations are the same as those in the first embodiment.

【0024】《実施例3》本実施例では、上記実施例1
の800g の乳糖に代えて、300g の乳糖と500g
のショ糖との混合物を用いた。その他の操作については
実施例1と同様である。
<< Embodiment 3 >> In this embodiment, the above-mentioned Embodiment 1 is used.
Instead of 800 g of lactose, 300 g of lactose and 500 g
Of sucrose was used. Other operations are the same as those in the first embodiment.

【0025】《実施例4》本実施例では、上記実施例1
の800g の乳糖に代えて、300g の乳糖と500g
の粉乳との混合物を用いた。その他の操作については実
施例1と同様である。
<Fourth Embodiment> In the present embodiment, the above-mentioned first embodiment is used.
Instead of 800 g of lactose, 300 g of lactose and 500 g
Was used as a mixture with milk powder. Other operations are the same as those in the first embodiment.

【0026】《実施例5》本実施例では、上記実施例1
の添加剤として、アスコルビン酸を投入していないもの
を用いた。従って、水酸化ナトリウムを用いての中性化
処理も必要ないものとされる。その他の操作については
実施例1と同様である。
<Fifth Embodiment> In the present embodiment, the above-mentioned first embodiment is used.
As the additive of the above, the one to which ascorbic acid was not added was used. Therefore, neutralization treatment with sodium hydroxide is not required. Other operations are the same as those in the first embodiment.

【0027】《実施例6》本実施例では、上記実施例1
の添加剤として、ゼラチンを投入していないものを用い
た。その他の操作については実施例1と同様である。
<Embodiment 6> In this embodiment, the above-mentioned embodiment 1 is used.
As the additive of (3), the one to which gelatin was not added was used. Other operations are the same as those in the first embodiment.

【0028】《実施例7》本実施例では、上記実施例1
の添加剤として、アスコルビン酸及びゼラチンを投入し
ていないものを用い、しかも800g の乳糖に代えて、
300g の乳糖と500g の粉乳との混合物を用いた。
アスコルビン酸を投入してないので、水酸化ナトリウム
を用いての中性化処理も必要ないものとされる。その他
の操作については実施例1と同様である。
<Embodiment 7> In the present embodiment, the above-mentioned Embodiment 1 is used.
Add ascorbic acid and gelatin as additives, and replace 800 g of lactose with
A mixture of 300 g lactose and 500 g milk powder was used.
Since ascorbic acid is not added, neutralization treatment with sodium hydroxide is not required. Other operations are the same as those in the first embodiment.

【0029】《実施例8》本実施例では、上記実施例1
の800g の乳糖と50g のゼラチンに代えて、270
g の乳糖と17g のゼラチンを用いた。その他の操作に
ついては実施例1と同様である。
<Embodiment 8> In the present embodiment, the above-mentioned Embodiment 1 is adopted.
270 instead of 800 g lactose and 50 g gelatin
Lactose (g) and 17 g of gelatin were used. Other operations are the same as those in the first embodiment.

【0030】《実施例9》本実施例では、上記実施例1
の添加剤として、アスコルビン酸を投入していないもの
を用い、しかも800g の乳糖と50g のゼラチンに代
えて、微量の乳糖とゼラチンを用いた。アスコルビン酸
を投入してないので、水酸化ナトリウムを用いての中性
化処理も必要ないものとされる。その他の操作について
は実施例1と同様である。
<< Embodiment 9 >> In this embodiment, the above-mentioned Embodiment 1 is used.
As an additive for the above, no ascorbic acid was added, and a trace amount of lactose and gelatin was used instead of 800 g of lactose and 50 g of gelatin. Since ascorbic acid is not added, neutralization treatment with sodium hydroxide is not required. Other operations are the same as those in the first embodiment.

【0031】《実施例10》本実施例では、上記実施例
1の800g の乳糖と50g のゼラチンに代えて、16
00g の乳糖と100g のゼラチンを用いた。その他の
操作については実施例1と同様である。
Example 10 In this example, 16 g of lactose and 50 g of gelatin in Example 1 were used instead of 16 g of lactose.
00 g of lactose and 100 g of gelatin were used. Other operations are the same as those in the first embodiment.

【0032】《実施例11》本実施例では、上記実施例
1の添加剤として、アスコルビン酸を投入していないも
のを用い、しかも800g の乳糖と50g のゼラチンに
代えて、1600gの乳糖と100g のゼラチンを用い
た。アスコルビン酸を投入してないので、水酸化ナトリ
ウムを用いての中性化処理も必要ないものとされる。そ
の他の操作については実施例1と同様である。
Example 11 In this example, as the additive of Example 1 above, ascorbic acid was not added, and 1600 g of lactose and 100 g of lactose were used instead of 800 g of lactose and 50 g of gelatin. Of gelatin was used. Since ascorbic acid is not added, neutralization treatment with sodium hydroxide is not required. Other operations are the same as those in the first embodiment.

【0033】《実施例12》本実施例では、ラクトハ゛チルス カ
゛ッセリー (Lactobacillus gasseri) の菌株と、ヒ゛フィト゛ハ゛クテ
リウム ロンク゛ム (Bifidobacterium longum)の菌株について
は、実施例5で用いた添加剤、即ち、実施例1の添加剤
にアスコルビン酸を投入していないもの(勿論、水酸化
ナトリウムを用いての中性化処理も必要ない。)を用
い、エシェリヒア コリ(Escherichia coli) の菌株については、
実施例1で用いた添加剤を用いた。その他の操作につい
ては実施例1と同様である。
Example 12 In this example, for the strain of Lactobacillus gasseri and the strain of Bifidobacterium longum, the additive used in Example 5, that is, Regarding the strain of Escherichia coli (Escherichia coli) using the additive of Example 1 without ascorbic acid (neutralization treatment with sodium hydroxide is not necessary, of course),
The additives used in Example 1 were used. Other operations are the same as those in the first embodiment.

【0034】《実施例13》本実施例では、ラクトハ゛チルス カ
゛ッセリー (Lactobacillus gasseri) の菌株、ヒ゛フィト゛ハ゛クテリウ
ム ロンク゛ム (Bifidobacterium longum)の菌株、エシェリヒア コリ
(Escherichia coli)の菌株の3種を混合して、前記実施
例1で用いた培地にて懸濁液を作製した。その他の操作
については実施例1と同様である。
Example 13 In this example, a strain of Lactobacillus gasseri, a strain of Bifidobacterium longum, and a strain of Escherichia coli were used.
Three strains of (Escherichia coli) were mixed to prepare a suspension in the medium used in Example 1 above. Other operations are the same as those in the first embodiment.

【0035】《実施例14》本実施例では、前記3種の
菌株を混合して、前記実施例5で使用した培地にて懸濁
液を作製した。その他の操作については実施例1と同様
である。
Example 14 In this example, the three strains were mixed and a suspension was prepared in the medium used in Example 5. Other operations are the same as those in the first embodiment.

【0036】《実施例15》本実施例では、細菌培養液
(I) として、全乳、或いは粉乳を投入していないものを
用い、該培養液(I) に下記方法にて作製した添加剤(II)
を混合し、懸濁培地(微生物含有培地)を作製した。そ
の他の操作については実施例1と同様で、プラグ−オン
型カプセル中には前記凍結乾燥物を200mg充填させて
保存した。
Example 15 In this example, a bacterial culture solution is used.
As (I), the whole milk or the one not containing milk powder is used, and the additive (II) prepared by the following method in the culture solution (I)
Were mixed to prepare a suspension medium (microorganism-containing medium). Other operations were the same as in Example 1, and 200 mg of the freeze-dried product was filled in the plug-on type capsule and stored.

【0037】前記添加剤(II)は、先ず、1200g の乳
糖(DAB 9) を2300mlの精製水(DAB 9) 中で加熱しな
がら溶解し、その液中にブルーム200のゼラチン(DAB
9)75g を加熱(25°C〜37°Cで)しながら溶
解する。
The additive (II) was prepared by first dissolving 1200 g of lactose (DAB 9) in 2300 ml of purified water (DAB 9) while heating and adding gelatin of Bloom 200 (DAB 9) to the solution.
9) Dissolve 75 g with heating (at 25 ° C to 37 ° C).

【0038】一方、13g のアスコルビン酸(DAB 9) を
250mlの精製水(DAB 9) 中で溶解し、3g の水酸化ナ
トリウムを用いて中性化(pH6.0以上)し、このア
スコルビン酸の中和液を前記乳糖とゼラチンの混合溶液
に加え、3種を混合することで作製する。
On the other hand, 13 g of ascorbic acid (DAB 9) was dissolved in 250 ml of purified water (DAB 9) and neutralized (pH 6.0 or more) with 3 g of sodium hydroxide. The neutralization solution is added to the mixed solution of lactose and gelatin to prepare three types of mixture.

【0039】次に、前記実施例1〜15における、保存
安定性試験の結果を詳述する。
Next, the results of the storage stability test in Examples 1 to 15 will be described in detail.

【0040】実施例1〜4及び実施例7の結果を下記表
2で示す。尚、表は保存年数3年での結果であり、保存
温度の条件はそれぞれ低温(4°C)、常温(室温
下)、高温(30°C)である。
The results of Examples 1 to 4 and Example 7 are shown in Table 2 below. The table shows the results after three years of storage, and the storage temperature conditions are low temperature (4 ° C), normal temperature (under room temperature), and high temperature (30 ° C), respectively.

【0041】[0041]

【表2】 [Table 2]

【0042】前記表2から考察されるように、細菌培養
液:炭水化物:ゼラチン:アスコルビン酸をその乾燥重
量比、8:16:1:0.5にて混合した微生物含有培
地(実施例1,2,3)の3年間保存後の生存率は大変
高く、特に4°Cでのラクトハ゛チルス カ゛ッセリー (Lactobacillus
gasseri) の菌株と、ヒ゛フィト゛ハ゛クテリウム ロンク゛ム (Bifidobac
terium longum)の菌株の生存率は80%に及ぶものであ
る。
As can be seen from Table 2 above, a microorganism-containing medium in which a bacterial culture solution: carbohydrate: gelatin: ascorbic acid was mixed at a dry weight ratio of 8: 16: 1: 0.5 (Example 1, 2 and 3) have a very high survival rate after storage for 3 years, especially Lactobacillus gasseri (Lactobacillus) at 4 ° C.
gasseri) and Bifidobacterium Long Bomb (Bifidobac
The survival rate of the terium longum) strain is as high as 80%.

【0043】また、前記炭水化物として乳糖を単独で用
いたり(実施例1)、ショ糖を単独で用いたり(実施例
2)、或いは乳糖とショ糖を混合して用いた(実施例
3)ものの生存率は高いが、粉乳を用いた(実施例4)
ものではあまり生存率は高くはならず、また、ゼラチン
やアスコルビン酸を使用しない(実施例7)と生存率は
かなり低下することがわかる。
In addition, lactose was used alone as the above-mentioned carbohydrate (Example 1), sucrose was used alone (Example 2), or lactose and sucrose were mixed (Example 3). Although the survival rate is high, powdered milk was used (Example 4).
It can be seen that the survival rate of the product is not so high, and that the survival rate is considerably reduced when gelatin or ascorbic acid is not used (Example 7).

【0044】次に、実施例5、6及び実施例8、9の結
果を下記表3で示す。尚、表は保存年数1、2、3年後
での結果であり、保存温度の条件はそれぞれ低温(4°
C〜8°C)、常温(20°C〜25°C)、高温(3
0°C)である。
The results of Examples 5 and 6 and Examples 8 and 9 are shown in Table 3 below. The table shows the results after 1, 2, and 3 years of storage, and the storage temperature conditions are low (4 ° C).
C-8 ° C), normal temperature (20 ° C-25 ° C), high temperature (3
0 ° C).

【0045】[0045]

【表3】 [Table 3]

【0046】前記表3から考察されるように、炭水化
物,ゼラチン,アスコルビン酸のいずれが欠けても生存
率は低くなり(実施例5,6,9)、また、前記実施例
1〜3と3年後のデータのみを比較するとわかるよう
に、その微生物含有培地の乾燥重量比が適当でない(実
施例8)と生存率、特に室温や高温での生存率はかなり
低下するといえる。
As can be seen from Table 3 above, the survival rate was low when any of carbohydrates, gelatin and ascorbic acid was lacking (Examples 5, 6 and 9), and also Examples 1 to 3 and 3 above. As can be seen by comparing only the data after a year, it can be said that if the dry weight ratio of the microorganism-containing medium is not appropriate (Example 8), the survival rate, especially at room temperature or high temperature, is considerably reduced.

【0047】次に、実施例10及び実施例11の結果を
下記表4で示す。尚、表はエシェリヒア コリ(Escherichia col
i) の菌株での結果のみであり、保存年数1,2,3年
後での実験結果であり、その保存温度の条件は低温(4
°C〜8°C)、室温(20°C〜25°C)である。
The results of Examples 10 and 11 are shown in Table 4 below. In addition, the table shows Escherichia col (Escherichia col
The results are only for the strain i) and the experimental results after 1, 2 and 3 years of storage, and the storage temperature conditions are low (4
° C to 8 ° C) and room temperature (20 ° C to 25 ° C).

【0048】[0048]

【表4】 [Table 4]

【0049】前記表4から考察されるように、エシェリヒア コ
リ(Escherichia coli) の菌株は、炭水化物:ゼラチンの
乾燥重量比を16:1にて混合したもの(実施例10)
であれば、細菌培養液に対して炭水化物とゼラチンの割
合が多くなった方(細菌培養液:炭水化物:ゼラチンが
2:16:1程度)が、その生存率は高い(低温保存で
は3年間不動の100%)ことがいえる。
As discussed in Table 4 above, the Escherichia coli strain was a mixture of carbohydrate: gelatin at a dry weight ratio of 16: 1 (Example 10).
In that case, the higher the ratio of carbohydrate and gelatin to the bacterial culture (bacterial culture: carbohydrate: gelatin is about 2: 16: 1), the higher the survival rate (immobilized for 3 years at low temperature storage). Of 100%).

【0050】また、前記エシェリヒア コリ(Escherichia coli)
の菌株は、アスコルビン酸にかなり左右され、該アスコ
ルビン酸を使用しない培地(実施例11)での保存は生
存率が極端に低下することもわかる。
The above Escherichia coli
It can also be seen that the strain of E. coli is highly dependent on ascorbic acid, and that storage in a medium that does not use ascorbic acid (Example 11) results in extremely low survival rate.

【0051】次に、実施例12〜実施例14の結果を下
記表5で示す。尚、表は保存年数1、2、3年後での結
果であり、保存温度の条件は低温(4°C〜8°C)、
常温(20°C〜25°C)である。
The results of Examples 12 to 14 are shown in Table 5 below. The table shows the results after 1, 2, and 3 years of storage, and the storage temperature conditions are low temperature (4 ° C to 8 ° C),
Normal temperature (20 ° C to 25 ° C).

【0052】[0052]

【表5】 [Table 5]

【0053】前記表5から考察されるように、前記実施
例1〜実施例11でいえることは、ラクトハ゛チルス カ゛ッセリー (L
actobacillus gasseri) の菌株、ヒ゛フィト゛ハ゛クテリウム ロンク゛ム
(Bifidobacterium longum)の菌株、エシェリヒア コリ(Escheric
hia coli) の菌株を混合した細胞培養液に前記添加剤を
加えて行った場合でも同様のことがいえ、特に、アスコ
ルビン酸は使用する細菌の感受性によって、感受性の小
さい細菌には少なく、感受性の大きい細菌は多くすれば
よいことがわかる。
As can be seen from Table 5 above, what can be said in Examples 1 to 11 is that Lactobacillus gasseri (L
Actobacillus gasseri) strain, Bifidobacterium longum
Escherichia coli strain (Bifidobacterium longum)
The same can be said when the above additives are added to a cell culture solution containing a mixture of (hia coli) strains, and in particular, ascorbic acid is less sensitive to less sensitive bacteria and less sensitive. It can be seen that the large bacteria should be increased.

【0054】従って、感受性の強いエシェリヒア コリ(Escheric
hia coli) の菌株を考慮し、アスコルビン酸の重量比を
全体に対して、0.1〜1.0の範囲内で適宜調節する
とよいことがいえる。
Therefore, the highly sensitive Escherichia coli (Escheric
It can be said that the weight ratio of ascorbic acid should be appropriately adjusted within the range of 0.1 to 1.0 in consideration of the strain of H. coli.

【0055】次に、実施例15の結果を図1で示す。
尚、図はラクトハ゛チルス カ゛ッセリー (Lactobacillus gasseri) の
菌株での結果であり、保存温度による生存率を比較した
グラフでで、保存年数1、2、3年後のものである。保
存温度の条件は低温(4°C)、常温(室温下)、高温
(30°C及び40°C)である。
Next, the results of Example 15 are shown in FIG.
The figure shows the results of the strain of Lactobacillus gasseri, which is a graph comparing the survival rates depending on the storage temperature, after 1, 2 and 3 years of storage. The storage temperature conditions are low temperature (4 ° C), normal temperature (under room temperature), and high temperature (30 ° C and 40 ° C).

【0056】図1からわかるように、細菌の種類によっ
ては、処理用菌株培地(I) に全乳、や粉乳を投入しない
方がその凍結乾燥物の生存率がよいものもあり、要は、
炭水化物:ゼラチン:アスコルビン酸の乾燥重量比が1
6:1:0.1〜16:1:1(内部相中含有量)にて
投入された培地を用いれば、凍結乾燥して、長期保存し
ても、細菌の生存能・生殖能は低下しないことがわか
る。
As can be seen from FIG. 1, depending on the type of bacteria, there is a case in which the survival rate of the freeze-dried product is better when whole milk or milk powder is not added to the strain culture medium (I) for treatment.
Carbohydrate: gelatin: ascorbic acid dry weight ratio of 1
If the culture medium input at 6: 1: 0.1 to 16: 1: 1 (content in the internal phase) is used, the viability and reproductive ability of the bacteria are reduced even when freeze-dried and stored for a long time. I know I won't.

【0057】以上の実施例より、添加剤(II)の種類によ
る安定性試験の相違をまとめたグラフを図2で示す。
尚、図2はエシェリヒア コリ(Escherichia coli) の菌株に対す
る結果であり、保存年数1〜2年の継続試験結果であ
る。
From the above examples, a graph summarizing the difference in stability test depending on the type of additive (II) is shown in FIG.
In addition, FIG. 2 shows the results for Escherichia coli strains, and the results of continuous tests for 1 to 2 years of storage.

【0058】図2からわかるように、微生物含有培地と
して炭水化物、ゼラチン、アスコルビン酸の3種を添加
すると、その相互作用によって、凍結乾燥した数年後ほ
とんど不変の生存率を示すことになる。
As can be seen from FIG. 2, when carbohydrates, gelatin, and ascorbic acid were added as the microorganism-containing medium, the interaction showed almost unchanged survival rate several years after freeze-drying.

【0059】以上の結果より、高度に感受性が相違する
ラクトハ゛チルス カ゛ッセリー (Lactobacillus gasseri) の菌株、ヒ゛
フィト゛ハ゛クテリウム ロンク゛ム (Bifidobacterium longum)の菌株、
エシェリヒア コリ(Escherichia coli) の菌株を同培地にて凍結
乾燥をするに際して、その凍結乾燥物が数年間に渡り、
比較的単純な貯蔵条件下(8°C以下の遮光防湿状態)
にて、生存能や生殖能を確実に保証するためには、前記
凍結乾燥前の微生物含有培地中に投与する種々の補助
剤、分散剤、保護剤、担体等の添加剤(II)として、炭水
化物:ゼラチン:アスコルビン酸をその乾燥重量比、1
6:1:0.1〜16:1:1にて投入すればよく、前
記炭水化物としては乳糖、ショ糖、或いは2種混合物を
用いることが特に好ましいことがわかった。
From the above results, the strains of Lactobacillus gasseri and the strains of Bifidobacterium longum, which are highly different in sensitivity,
When freeze-drying a strain of Escherichia coli in the same medium, the freeze-dried product was used for several years,
Relatively simple storage conditions (shading and humidity protection below 8 ° C)
In order to ensure the viability and fertility, various auxiliary agents to be administered in the microorganism-containing medium before lyophilization, dispersants, protective agents, as additives such as carriers (II), Carbohydrate: Gelatin: Ascorbic acid in a dry weight ratio of 1
It was found that it is sufficient to add at 6: 1: 0.1 to 16: 1: 1, and it has been found that it is particularly preferable to use lactose, sucrose, or a mixture of two kinds as the carbohydrate.

【0060】また、上記添加剤(II)の条件を適宜調節す
ることで、常温下(通常の大気中の室内条件下)でも市
販可能製品に処理できるようになり、この凍結乾燥物は
医薬品等の薬剤としても利用することができるようにな
る。
Further, by appropriately adjusting the conditions of the additive (II), it becomes possible to process into a commercially available product even at room temperature (normal indoor conditions in the atmosphere). It will also be available as a drug.

【0061】[0061]

【発明の効果】本発明では、微生物含有培地の凍結乾燥
物を製造する際、その微生物含有培地として、炭水化
物,ゼラチン,アスコルビン酸をその乾燥重量比、1
6:1:0.1〜16:1:1にて投入しているので、
それらの相互作用(主に炭水化物が補助剤、或いは保護
剤、ゼラチンが分散剤、アスコルビン酸が酸化防止剤と
して作用する)によって、この凍結乾燥物は、低温下は
勿論、常温、場合によっては高温下においても、湿度、
温度、及び大気中の酸素による生存能や生殖能の劣化を
充分に制御し、長期的な安全性保存が可能となる。従っ
て、この凍結乾燥物を薬剤に使用することも可能とな
る。
INDUSTRIAL APPLICABILITY In the present invention, when a freeze-dried product of a microorganism-containing medium is produced, carbohydrate, gelatin, and ascorbic acid are used as the microorganism-containing medium in a dry weight ratio of 1: 1.
Since it is input at 6: 1: 0.1 to 16: 1: 1,
Due to their interactions (mainly carbohydrate acts as an auxiliary or protective agent, gelatin acts as a dispersant, and ascorbic acid acts as an antioxidant), this lyophilizate is not only cold but at room temperature, and in some cases at high temperature. Even under the humidity,
The deterioration of viability and fertility due to temperature and atmospheric oxygen can be sufficiently controlled, and long-term safe preservation can be achieved. Therefore, this freeze-dried product can be used as a drug.

【図面の簡単な説明】[Brief description of drawings]

【図1】保存温度の違いによる安定性試験の結果を示す
グラフ。
FIG. 1 is a graph showing the results of stability tests depending on the difference in storage temperature.

【図2】凍結乾燥物の培地の違いによる安定性試験の結
果を示すグラフ。
FIG. 2 is a graph showing the results of stability tests depending on the medium of the lyophilized product.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C12R 1:01) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Office reference number FI technical display location C12R 1:01)

Claims (14)

【特許請求の範囲】[Claims] 【請求項1】 生存能,生殖能を保持する細菌を含有す
る微生物含有培地の凍結乾燥物において、前記培地中
に、乾燥重量比が16:1:0.1〜16:1:1(内
部相中含有量)の炭水化物,ゼラチン,アスコルビン酸
の混合物が添加され、且つ該培地が凍結乾燥されている
ことを特徴とする微生物含有培地の凍結乾燥物。
1. A freeze-dried product of a microorganism-containing medium containing a bacterium that retains viability and fertility, wherein the dry weight ratio in the medium is 16: 1: 0.1 to 16: 1: 1 (internal A lyophilized product of a microorganism-containing medium, characterized in that a mixture of carbohydrates, gelatin and ascorbic acid having a phase content) is added, and the medium is lyophilized.
【請求項2】 前記細菌が、アシト゛フィルス(Acidophilus)の
菌株、ヒ゛フィト゛ハ゛クテリウム(Bifidobacterium) の菌株、エシェリヒ
ア コリ(Escherichia coli) の菌株であることを特徴とす
る請求項1記載の微生物含有培地の凍結乾燥物。
2. The microorganism-containing medium according to claim 1, wherein the bacterium is a strain of Acidophilus, a strain of Bifidobacterium, or a strain of Escherichia coli. Lyophilized product.
【請求項3】 前記細菌の凍結乾燥物の微生物含有培地
は、乾燥重量比が8:16:1:0.5(内部相中含有
量)の細菌培養液,炭水化物,ゼラチン,アスコルビン
酸の混合物であることを特徴とする請求項1又は請求項
2に記載の微生物含有培地の凍結乾燥物。
3. The microbial-containing medium of the freeze-dried product of bacteria is a mixture of a bacterial culture solution having a dry weight ratio of 8: 16: 1: 0.5 (content in the internal phase), carbohydrate, gelatin, and ascorbic acid. The freeze-dried product of the microorganism-containing medium according to claim 1 or 2.
【請求項4】 前記細菌の凍結乾燥物の微生物含有培地
は、乾燥重量比が2:16:1:0.2(内部相中含有
量)の細菌培養液,炭水化物,ゼラチン,アスコルビン
酸の混合物であることを特徴とする請求項1又は請求項
2に記載の微生物含有培地の凍結乾燥物。
4. The microbial-containing medium of the lyophilized product of the bacterium is a mixture of a bacterial culture solution having a dry weight ratio of 2: 16: 1: 0.2 (content in the internal phase), carbohydrate, gelatin, and ascorbic acid. The freeze-dried product of the microorganism-containing medium according to claim 1 or 2.
【請求項5】 前記炭水化物は、一物質又は複数物質の
混合物からなることを特徴とする請求項1〜4のいずれ
かに記載の微生物含有培地の凍結乾燥物。
5. The freeze-dried product of the microorganism-containing medium according to claim 1, wherein the carbohydrate comprises one substance or a mixture of a plurality of substances.
【請求項6】 前記炭水化物が乳糖であることを特徴と
する請求項1〜5のいずれかに記載の微生物含有培地の
凍結乾燥物。
6. The freeze-dried product of the microorganism-containing medium according to claim 1, wherein the carbohydrate is lactose.
【請求項7】 前記炭水化物がショ糖であることを特徴
とする請求項1〜5のいずれかに記載の微生物含有培地
の凍結乾燥物。
7. The freeze-dried product of the microorganism-containing medium according to claim 1, wherein the carbohydrate is sucrose.
【請求項8】 前記炭水化物が乳糖とショ糖の混合物で
あることを特徴とする請求項1〜5のいずれかに記載の
微生物含有培地の凍結乾燥物。
8. The freeze-dried product of the microorganism-containing medium according to claim 1, wherein the carbohydrate is a mixture of lactose and sucrose.
【請求項9】 炭水化物:ゼラチン:アスコルビン酸を
その乾燥重量比、16:1:0.1〜16:1:1にて
混合し、細菌培養液中に投入して微生物含有培地を作製
し、次いで該培地を凍結乾燥して製造することを特徴と
する微生物含有培地の凍結乾燥物の製造方法。
9. Carbohydrate: gelatin: ascorbic acid are mixed at a dry weight ratio of 16: 1: 0.1 to 16: 1: 1 and added to a bacterial culture to prepare a microorganism-containing medium. Next, a method for producing a freeze-dried product of a microorganism-containing medium, which comprises freeze-drying the medium.
【請求項10】 細菌培養液:炭水化物:ゼラチン:ア
スコルビン酸をその乾燥重量比、8:16:1:0.5
にて混合し、微生物含有培地を作製し、次いで該培地を
凍結乾燥して製造することを特徴とする微生物含有培地
の凍結乾燥物の製造方法。
10. Bacterial culture: carbohydrate: gelatin: ascorbic acid in a dry weight ratio of 8: 16: 1: 0.5.
The method for producing a freeze-dried product of a microorganism-containing medium, the method comprising mixing the microorganisms to prepare a microorganism-containing medium, and then freeze-drying the medium.
【請求項11】 細菌培養液:炭水化物:ゼラチン:ア
スコルビン酸をその乾燥重量比、2:16:1:0.2
にて混合し、微生物含有培地を作製し、次いで該培地を
凍結乾燥して製造することを特徴とする微生物含有培地
の凍結乾燥物の製造方法。
11. Bacterial culture: carbohydrate: gelatin: ascorbic acid in a dry weight ratio of 2: 16: 1: 0.2.
The method for producing a freeze-dried product of a microorganism-containing medium, the method comprising mixing the microorganisms to prepare a microorganism-containing medium, and then freeze-drying the medium.
【請求項12】 前記培地中の炭水化物は、一物質又は
複数物質の混合物であることを特徴とする請求項9〜1
1のいずれかに記載の微生物含有培地の凍結乾燥物の製
造方法。
12. The carbohydrate in the medium is one substance or a mixture of a plurality of substances, wherein the carbohydrate is one of the substances.
1. A method for producing a freeze-dried product of a microorganism-containing medium according to any one of 1.
【請求項13】 前記培地中の炭水化物が、乳糖とショ
糖の混合物であることを特徴とする請求項9〜12のい
ずれかに記載の微生物含有培地の凍結乾燥物の製造方
法。
13. The method for producing a freeze-dried product of a microorganism-containing medium according to any one of claims 9 to 12, wherein the carbohydrate in the medium is a mixture of lactose and sucrose.
【請求項14】 前記請求項1〜請求項8のいずれかに
記載の微生物含有培地の凍結乾燥物を有効成分として含
有することを特徴とする薬剤。
14. A drug comprising the freeze-dried product of the microorganism-containing medium according to any one of claims 1 to 8 as an active ingredient.
JP4159776A 1992-06-18 1992-06-18 Lyophilized product of microorganism-containing medium and method for producing the same Expired - Lifetime JP2558203B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4159776A JP2558203B2 (en) 1992-06-18 1992-06-18 Lyophilized product of microorganism-containing medium and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4159776A JP2558203B2 (en) 1992-06-18 1992-06-18 Lyophilized product of microorganism-containing medium and method for producing the same

Publications (2)

Publication Number Publication Date
JPH0622746A true JPH0622746A (en) 1994-02-01
JP2558203B2 JP2558203B2 (en) 1996-11-27

Family

ID=15701020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4159776A Expired - Lifetime JP2558203B2 (en) 1992-06-18 1992-06-18 Lyophilized product of microorganism-containing medium and method for producing the same

Country Status (1)

Country Link
JP (1) JP2558203B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012021783A3 (en) * 2010-08-13 2012-05-31 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
US9731020B2 (en) 2010-01-28 2017-08-15 Advanced Bionutrition Corp. Dry glassy composition comprising a bioactive material
US9737578B2 (en) 2005-12-28 2017-08-22 Advanced Bionutrition Corp. Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US10206421B2 (en) 2010-01-28 2019-02-19 Advanced Bionutrition Corp. Stabilizing composition for biological materials
US10953050B2 (en) 2015-07-29 2021-03-23 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
US11214597B2 (en) 2009-05-26 2022-01-04 Advanced Bionutrition Corp. Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9737578B2 (en) 2005-12-28 2017-08-22 Advanced Bionutrition Corp. Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
US11214597B2 (en) 2009-05-26 2022-01-04 Advanced Bionutrition Corp. Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US9731020B2 (en) 2010-01-28 2017-08-15 Advanced Bionutrition Corp. Dry glassy composition comprising a bioactive material
US10206421B2 (en) 2010-01-28 2019-02-19 Advanced Bionutrition Corp. Stabilizing composition for biological materials
US10575545B2 (en) 2010-01-28 2020-03-03 Advanced Bionutrition Corp. Stabilizing composition for biological materials
WO2012021783A3 (en) * 2010-08-13 2012-05-31 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials
KR20140019766A (en) * 2010-08-13 2014-02-17 어드밴스드 바이오뉴트리션 코포레이션 Dry storage stabilizing composition for biological materials
US10953050B2 (en) 2015-07-29 2021-03-23 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses

Also Published As

Publication number Publication date
JP2558203B2 (en) 1996-11-27

Similar Documents

Publication Publication Date Title
CA2580949C (en) Metabolically active micro organisms and methods for their production
US5501857A (en) Oral nutritional and dietary composition
Grosso et al. Stability of free and immobilized Lactobacillus acidophilus and Bifidobacterium lactis in acidified milk and of immobilized B. lactis in yoghurt
JP2002513559A (en) Dried microbial culture and method for producing the same
US4396631A (en) Bifidobacterium-containing confectionery tablets and process for preparing the same
EP3585406B1 (en) Preparation of dry formulations of dairy probiotics.
EP0196593B1 (en) Process to preserve acid-producing bacteria and compositions produced thereby
US4147773A (en) Powdery composition comprising viable Bifidobacteria cells and lactulose
JP2558203B2 (en) Lyophilized product of microorganism-containing medium and method for producing the same
JP3017456B2 (en) High-concentration culture method and culture product of propionic acid bacteria and processed product thereof
EP0569623B1 (en) Microorganisms containing lyophilizate of a culture medium with proliferous germs
EP1213347A1 (en) A method for preserving cells by processing the same into dry products
GB1582068A (en) Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder
LU502503B1 (en) Probiotic composition for vaginal health, and preparation method and use thereof
KR102004204B1 (en) lactic acid bacteria improved stability and preparing method thereof
Woo et al. Improvement of Bifidobacterium longum stability using cell-entrapment technique
CN107189968B (en) Enterococcus faecalis and preparation method thereof
CN115197847B (en) Probiotic freeze-dried tablet and preparation method thereof
JPS61265085A (en) Production of powder of cultured bifidus bacillus having excellent storage stability of living cell
KR102607676B1 (en) Probiotics composition for companion animals comprising aerotolerant Bifidobacterium strain as effective component and production method thereof
Atwa et al. Lactic acid bacteria: economic propagation, chitinases activity, and enhancing viability by gel encapsulation
RU2149008C1 (en) Method of biopreparation preparing
HU193294B (en) Preparation influencing the digestion of ruminants advantageously
JPS63251080A (en) Production of powder containing cell of bifidobacterium
CA3148737A1 (en) Homogenisation process for the preparation of a cellular component homogenate

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080905

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080905

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090905

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090905

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100905

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100905

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110905

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110905

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120905

Year of fee payment: 16

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120905

Year of fee payment: 16